268 related articles for article (PubMed ID: 27802328)
1. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
[TBL] [Abstract][Full Text] [Related]
2. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
[TBL] [Abstract][Full Text] [Related]
4. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients with late-onset multiple sclerosis.
Kis B; Rumberg B; Berlit P
J Neurol; 2008 May; 255(5):697-702. PubMed ID: 18283394
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
[TBL] [Abstract][Full Text] [Related]
7. Effect of gender on late-onset multiple sclerosis.
Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
[TBL] [Abstract][Full Text] [Related]
8. Late onset multiple sclerosis: concerns in aging patients.
Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
[TBL] [Abstract][Full Text] [Related]
9. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
[TBL] [Abstract][Full Text] [Related]
10. Late-onset MS is associated with an increased rate of reaching disability milestones.
Andersen MA; Buron MD; Magyari M
J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a late-onset multiple sclerosis Portuguese cohort.
Moura J; Duarte S; Oliveira V; Pereira D; Costa D; Samões R; Sousa AP; Silva AM; Santos E
Mult Scler Relat Disord; 2023 Feb; 70():104506. PubMed ID: 36638770
[TBL] [Abstract][Full Text] [Related]
12. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; De Keyser J
Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
[TBL] [Abstract][Full Text] [Related]
13. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
Lorefice L; Ferraro OE; Fenu G; Amato MP; Bresciamorra V; Conte A; De Luca G; Ferraro D; Filippi M; Gazzola P; Iaffaldano P; Inglese M; Lus G; Marfia GA; Patti F; Pesci I; Salemi G; Trojano M; Zaffaroni M; Monti MC; Cocco E;
J Neurol; 2024 Apr; 271(4):1630-1637. PubMed ID: 38172380
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Shirani A; Zhao Y; Petkau J; Gustafson P; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Tremlett H
Biomed Res Int; 2015; 2015():451912. PubMed ID: 25922836
[TBL] [Abstract][Full Text] [Related]
15. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
Usta NC; Boz C; Terzi M
Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
[TBL] [Abstract][Full Text] [Related]
17. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
[TBL] [Abstract][Full Text] [Related]
18. Natural history of multiple sclerosis in a population-based cohort.
Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
[TBL] [Abstract][Full Text] [Related]
19. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
[TBL] [Abstract][Full Text] [Related]
20. Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.
Butler Pagnotti R; Hua LH; Miller JB
Mult Scler; 2022 May; 28(6):933-941. PubMed ID: 34410177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
